Your browser doesn't support javascript.
loading
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme.
Ohashi, Riuko; Martignoni, Guido; Hartmann, Arndt; Caliò, Anna; Segala, Diego; Stöhr, Christine; Wach, Sven; Erlmeier, Franziska; Weichert, Wilko; Autenrieth, Michael; Schraml, Peter; Rupp, Niels J; Ohe, Chisato; Otsuki, Yoshiro; Kawasaki, Takashi; Kobayashi, Hiroshi; Kobayashi, Kazuhiro; Miyazaki, Tatsuhiko; Shibuya, Hiroyuki; Usuda, Hiroyuki; Umezu, Hajime; Fujishima, Fumiyoshi; Furusato, Bungo; Osakabe, Mitsumasa; Sugai, Tamotsu; Kuroda, Naoto; Tsuzuki, Toyonori; Nagashima, Yoji; Ajioka, Yoichi; Moch, Holger.
Afiliação
  • Ohashi R; Histopathology Core Facility, Niigata University Faculty of Medicine, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan.
  • Martignoni G; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Schmelzbergstrasse 12, CH-8091, Zurich, Switzerland.
  • Hartmann A; Division of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan.
  • Caliò A; Department of Diagnostic and Public Health, University of Verona, Piazzale Ludovico Antonio Scuro 10, 37134, Verona, Italy.
  • Segala D; Department of Pathology, Pederzoli Hospital, Via Monte Baldo 24, 37019, Peschiera del Garda, Italy.
  • Stöhr C; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 8-10, 91054, Erlangen, Germany.
  • Wach S; Department of Diagnostic and Public Health, University of Verona, Piazzale Ludovico Antonio Scuro 10, 37134, Verona, Italy.
  • Erlmeier F; Department of Pathology, Pederzoli Hospital, Via Monte Baldo 24, 37019, Peschiera del Garda, Italy.
  • Weichert W; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 8-10, 91054, Erlangen, Germany.
  • Autenrieth M; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054, Erlangen, Germany.
  • Schraml P; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstrasse 8-10, 91054, Erlangen, Germany.
  • Rupp NJ; Institute of Pathology, Technical University Munich, Trogerstrasse 18, 81675, Munich, Germany.
  • Ohe C; Institute of Pathology, Technical University Munich, Trogerstrasse 18, 81675, Munich, Germany.
  • Otsuki Y; Department of Urology, Technical University Munich, Klinikum rechts der Isar, Ismaninger Strasse 22, 81675, Munich, Germany.
  • Kawasaki T; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Schmelzbergstrasse 12, CH-8091, Zurich, Switzerland.
  • Kobayashi H; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Schmelzbergstrasse 12, CH-8091, Zurich, Switzerland.
  • Kobayashi K; Department of Pathology and Laboratory Medicine, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, 573-1010, Japan.
  • Miyazaki T; Department of Pathology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Naka-ku, Hamamatsu, 430-8558, Japan.
  • Shibuya H; Department of Pathology, Niigata Cancer Center Hospital, 2-15-3 Kawagishi-cho, Chuo-ku, Niigata, 951-8566, Japan.
  • Usuda H; Department of Pathology, Tachikawa General Hospital, 1-24 Asahioka, Nagaoka, 940-8621, Japan.
  • Umezu H; Department of Pathology, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
  • Fujishima F; Department of Pathology, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
  • Furusato B; Department of Pathology, Niigata City General Hospital, 463-7 Shumoku, Chuo-ku, Niigata, 950-1197, Japan.
  • Osakabe M; Department of Diagnostic Pathology, Nagaoka Red Cross Hospital, 2-297-1 Sensyu, Nagaoka, 940-2085, Japan.
  • Sugai T; Division of Pathology, Niigata University Medical & Dental Hospital, 1-754 Asahimachi-dori, Chuo-ku, Niigata, 951-8520, Japan.
  • Kuroda N; Department of Anatomic Pathology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
  • Tsuzuki T; Cancer Genomics Unit, Clinical Genomics Center, Nagasaki University Hospital, 1-7-1, Sakamoto, Nagasaki, 852-8501, Japan.
  • Nagashima Y; Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1, Sakamoto, Nagasaki, 852-8501, Japan.
  • Ajioka Y; Department of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University, 2-1-1, Idai-dori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
  • Moch H; Department of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University, 2-1-1, Idai-dori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan.
Virchows Arch ; 476(3): 409-418, 2020 Mar.
Article em En | MEDLINE | ID: mdl-31760491
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Gradação de Tumores / Neoplasias Renais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Gradação de Tumores / Neoplasias Renais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article